TwinKnowledge | $3,700,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
Certified by Founder
Lodge
Psylo
start up
Australia
- Sydney, NSW
- 04/06/2024
- Seed
- $8,000,000
Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. We are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.
- Industry Biotechnology
- Website https://psylo.bio/
- LinkedIn https://www.linkedin.com/company/psylo/
SchoolAI | $25,000,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Cambrian Network | $5,900,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)